70 related articles for article (PubMed ID: 18639600)
1. Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia.
Köchling J; Prada J; Bahrami M; Stripecke R; Seeger K; Henze G; Wittig B; Schmidt M
Vaccine; 2008 Aug; 26(36):4669-75. PubMed ID: 18639600
[TBL] [Abstract][Full Text] [Related]
2. Prevention and synergistic control of Ph(+) ALL by a DNA vaccine and 6-mercaptopurine.
Köchling J; Rott Y; Arndt S; Marschke C; Schmidt M; Wittig B; Kalies K; Westermann J; Henze G
Vaccine; 2012 Sep; 30(41):5949-55. PubMed ID: 22841975
[TBL] [Abstract][Full Text] [Related]
3. Protection of mice against Philadelphia chromosome-positive acute lymphoblastic leukemia by cell-based vaccination using nonviral, minimalistic expression vectors and immunomodulatory oligonucleotides.
Köchling J; König-Merediz SA; Stripecke R; Buchwald D; Korte A; Von Einsiedel HG; Sack F; Henze G; Seeger K; Wittig B; Schmidt M
Clin Cancer Res; 2003 Aug; 9(8):3142-9. PubMed ID: 12912966
[TBL] [Abstract][Full Text] [Related]
4. DNA immunisation with minimalistic expression constructs.
Moreno S; López-Fuertes L; Vila-Coro AJ; Sack F; Smith CA; Konig SA; Wittig B; Schroff M; Juhls C; Junghans C; Timón M
Vaccine; 2004 Apr; 22(13-14):1709-16. PubMed ID: 15068854
[TBL] [Abstract][Full Text] [Related]
5. Can anthocyanins improve maintenance therapy of Ph(+) acute lymphoblastic leukaemia?
Köchling J; Schmidt M; Rott Y; Sagner M; Ungefroren H; Wittig B; Henze G
Eur J Haematol; 2013 Apr; 90(4):291-300. PubMed ID: 23294316
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
Rinaldi M; Fioretti D; Iurescia S; Signori E; Pierimarchi P; Seripa D; Tonon G; Fazio VM
Biochem Biophys Res Commun; 2008 May; 370(2):279-84. PubMed ID: 18364239
[TBL] [Abstract][Full Text] [Related]
7. Requirement for NK cells in CD40 ligand-mediated rejection of Philadelphia chromosome-positive acute lymphoblastic leukemia cells.
Gruber TA; Skelton DC; Kohn DB
J Immunol; 2002 Jan; 168(1):73-80. PubMed ID: 11751948
[TBL] [Abstract][Full Text] [Related]
8. An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
Dharmapuri S; Aurisicchio L; Neuner P; Verdirame M; Ciliberto G; La Monica N
Cancer Gene Ther; 2009 May; 16(5):462-72. PubMed ID: 18989354
[TBL] [Abstract][Full Text] [Related]
9. Recombinant murine interleukin-12 elicits potent antileukemic immune responses in a murine model of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Gruber TA; Skelton DC; Kohn DB
Cancer Gene Ther; 2005 Oct; 12(10):818-24. PubMed ID: 15877085
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
11. Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.
Ni J; Nolte B; Arnold A; Fournier P; Schirrmacher V
Vaccine; 2009 Sep; 27(40):5480-7. PubMed ID: 19616491
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
[TBL] [Abstract][Full Text] [Related]
13. Minimal size MIDGE vectors improve transgene expression in vivo.
Schakowski F; Gorschlüter M; Buttgereit P; Märten A; Lilienfeld-Toal MV; Junghans C; Schroff M; König-Merediz SA; Ziske C; Strehl J; Sauerbruch T; Wittig B; Schmidt-Wolf IG
In Vivo; 2007; 21(1):17-23. PubMed ID: 17354609
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
15. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
16. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
Mennuni C; Ugel S; Mori F; Cipriani B; Iezzi M; Pannellini T; Lazzaro D; Ciliberto G; La Monica N; Zanovello P; Bronte V; Scarselli E
Cancer Res; 2008 Dec; 68(23):9865-74. PubMed ID: 19047167
[TBL] [Abstract][Full Text] [Related]
17. Effective anti-tumor responses induced by recombinant bacillus Calmette-Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF.
Yuan S; Shi C; Han W; Ling R; Li N; Wang T
Eur J Cancer Prev; 2009 Sep; 18(5):416-23. PubMed ID: 19550341
[TBL] [Abstract][Full Text] [Related]
18. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
[TBL] [Abstract][Full Text] [Related]
19. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
Mortara L; Frangione V; Castellani P; De Lerma Barbaro A; Accolla RS
Int Immunol; 2009 Jun; 21(6):655-65. PubMed ID: 19395374
[TBL] [Abstract][Full Text] [Related]
20. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
